カテゴリ： GlobalData, アメリカ, 企業調査

Ameren Corporation (AEE)-エネルギー分野：企業M&A・提携分析

◆英語タイトル：Ameren Corporation (AEE) - Power - Deals and Alliances Profile
◆商品コード：DATA8013040
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月27日
◆ページ数：76
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：発電・エネルギー
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Ameren Corporation (Ameren) is a public utility holding company that generates, transmits and distributes electricity; and transmits and distributes natural gas through its subsidiaries. The company generates electricity through varied energy sources such as coal, nuclear, hydro, solar, natural gas and methane gas. It serves residential, commercial and industrial customers. Ameren is headquartered in St. Louis, Missouri, the US.

Ameren Corporation (AEE) – Power – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ameren Corporation, Power, Deals By Year, 2011 to YTD 2017 6
Ameren Corporation, Power Deals By Type, 2011 to YTD 2017 7
Ameren Corporation, Power, Deals By Region, 2011 to YTD 2017 8
Ameren Corporation, Power, Deals By Sector, 2011 to YTD 2017 9
Ameren Corporation, Power, Deals Summary, 2011 to YTD 2017 10
Ameren Corporation, Power, Deal Details 12
Debt Offering 12
Ameren Illinois Prices Public Offering of 3.7% Bonds Due 2047 for USD500 Million 12
Ameren to Raise USD450 Million in private placement of 3.43% Notes Due 2050 14
Union Electric Raises USD400 Million in Public Offering of 2.95% Notes Due 2027 17
Ameren Illinois Raises USD240 Million in Public Offering of 4.15% Notes Due 2046 19
Union Electric Raises USD150 Million in Public Offering of 3.65% Notes Due 2045 20
Ameren Illinois Raises USD250 Million in Public Offering of 4.15% Notes Due 2046 22
Ameren Raises USD350 Million in Public Offering of 2.7% Notes Due 2020 23
Ameren Raises USD350 Million in Public Offering of 3.65% Notes Due 2026 25
Union Electric Raises USD250 Million in Public Offering of 3.65% Notes Due 2045 27
Ameren Illinois Raises USD300 Million in Public Offering of 3.25% Notes Due 2025 29
Ameren Illinois Raises USD250 Million in Public Offering of 4.3% Notes Due 2044 30
Ameren Missouri Completes Public Offering Of 3.5% Notes Due 2024 For US$350 Million 31
Ameren Illinois Completes Public Offering Of 4.8% Notes Due 2043 For US$280 Million 32
Union Electric Completes Public Offering Of 3.9% Notes Due 2042 For US$485 Million 33
Ameren Illinois Completes Public Offering Of 2.7% Notes Due 2022 For US$400 Million 35
Asset Transactions 36
Rockland Capital Completes Project Financing Of US$50 Million For The Acquistion Of Elgin Energy Center Gas Fired Power Plant In US 36
Ameren To Sell Coffeen Coal Fired Power Plant To Dynegy 37
Ameren To Sell Newton Coal Fired Power Plant To Dynegy 38
Ameren To Sell Joppa Coal Fired Power Plant To Dynegy 39
Acquisition 40
Illinois Power Completes Acquisition Of Ameren Energy Resources From Ameren 40
Ameren Corporation – Key Competitors 41
Ameren Corporation – Key Employees 42
Ameren Corporation – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 46
Nov 03, 2017: Ameren Announces Third Quarter 2017 Results 46
Oct 26, 2017: First-ever Ameren Accelerator Demo Day showcases cutting-edge energy technologies 48
Sep 10, 2017: Ameren to build new substation, power lines in Normal 50
Aug 17, 2017: S&C and Ameren Conduct Successful 24-hour Islanding Test on Microgrid 51
Aug 04, 2017: Ameren Announces Second Quarter 2017 Results 52
Jul 11, 2017: TransCanada Joins Energy Impact Partners Global Utility Coalition 54
Jun 05, 2017: ATXI and Northeast Power seek landowner feedback on the Mark Twain Transmission Project 55
May 18, 2017: Ameren unveils one of North America’s most advanced distributed energy resource facilities 56
May 04, 2017: Ameren Announces First Quarter 2017 Results and Affirms 2017 Earnings Guidance 57
Apr 27, 2017: Ameren Releases 2017 Corporate Social Responsibility Report 59
Apr 19, 2017: Construction Begins on Bagnell Dam at Lake of the Ozarks 60
Mar 31, 2017: Ameren launches initiative to spark energy innovation and attract job-creating tech startups to St. Louis 61
Mar 16, 2017: Ameren Announces Promotion of Shawn Schukar to Chairman and President of Ameren Transmission Company 63
Feb 16, 2017: Ameren Announces 2016 Results and Issues 2017 Earnings Guidance 64
Nov 04, 2016: Ameren Announces Third Quarter 2016 Results And Raises 2016 Earnings Guidance Range 66
Sep 28, 2016: Avista Corp. Joins Energy Impact Partners Utility Coalition 68
Aug 05, 2016: Ameren Announces Second Quarter 2016 Results 69
Jun 07, 2016: Ameren Joins Energy Impact Partners Utility Coalition 71
May 10, 2016: Ameren Announces First Quarter 2016 Results And Affirms 2016 Earnings Guidance 72
Apr 28, 2016: Ameren shares 2016 Corporate Social Responsibility Report 73
Feb 19, 2016: Ameren Announces 2015 Results And Issues Earnings Guidance 74
Appendix 76
Methodology 76
About GlobalData 76
Contact Us 76
Disclaimer 76

List of Tables
Ameren Corporation, Power, Key Facts, 2016 2
Ameren Corporation, Power, Deals Summary, 2011 to YTD 2017 2
Ameren Corporation, Power, Deals By Year, 2011 to YTD 2017 6
Ameren Corporation, Power Deals By Type, 2011 to YTD 2017 7
Ameren Corporation, Power, Deals By Region, 2011 to YTD 2017 8
Ameren Corporation, Deals By Sector, 2011 to YTD 2017 9
Ameren Corporation, Power, Deals Summary, 2011 to YTD 2017 10
Ameren Illinois Prices Public Offering of 3.7% Bonds Due 2047 for USD500 Million 12
Ameren to Raise USD450 Million in private placement of 3.43% Notes Due 2050 14
Union Electric Raises USD400 Million in Public Offering of 2.95% Notes Due 2027 17
Ameren Illinois Raises USD240 Million in Public Offering of 4.15% Notes Due 2046 19
Union Electric Raises USD150 Million in Public Offering of 3.65% Notes Due 2045 20
Ameren Illinois Raises USD250 Million in Public Offering of 4.15% Notes Due 2046 22
Ameren Raises USD350 Million in Public Offering of 2.7% Notes Due 2020 23
Ameren Raises USD350 Million in Public Offering of 3.65% Notes Due 2026 25
Union Electric Raises USD250 Million in Public Offering of 3.65% Notes Due 2045 27
Ameren Illinois Raises USD300 Million in Public Offering of 3.25% Notes Due 2025 29
Ameren Illinois Raises USD250 Million in Public Offering of 4.3% Notes Due 2044 30
Ameren Missouri Completes Public Offering Of 3.5% Notes Due 2024 For US$350 Million 31
Ameren Illinois Completes Public Offering Of 4.8% Notes Due 2043 For US$280 Million 32
Union Electric Completes Public Offering Of 3.9% Notes Due 2042 For US$485 Million 33
Ameren Illinois Completes Public Offering Of 2.7% Notes Due 2022 For US$400 Million 35
Rockland Capital Completes Project Financing Of US$50 Million For The Acquistion Of Elgin Energy Center Gas Fired Power Plant In US 36
Ameren To Sell Coffeen Coal Fired Power Plant To Dynegy 37
Ameren To Sell Newton Coal Fired Power Plant To Dynegy 38
Ameren To Sell Joppa Coal Fired Power Plant To Dynegy 39
Illinois Power Completes Acquisition Of Ameren Energy Resources From Ameren 40
Ameren Corporation, Key Competitors 41
Ameren Corporation, Key Employees 42
Ameren Corporation, Subsidiaries 44

★海外企業調査レポート[Ameren Corporation (AEE)-エネルギー分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Vaxart Inc (AVIR)：企業の財務・戦略的SWOT分析
    Vaxart Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Phibro Animal Health Corp (PAHC)：企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Enterome Bioscience SA：医療機器：M&Aディール及び事業提携情報
    Summary Enterome Bioscience SA (Enterome) is a drug development company which develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome …
  • Xenon Pharmaceuticals Inc (XENE)：企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • Gujarat State Electricity Corporation Ltd：企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Northstar Aerospace Inc.：企業の戦略・SWOT・財務情報
    Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hal Trust
    Hal Trust - Strategy, SWOT and Corporate Finance Report Summary Hal Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • NewOcean Energy Holdings Ltd (342)：企業の財務・戦略的SWOT分析
    NewOcean Energy Holdings Ltd (342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Rocky Mountain Chocolate Factory, Inc.：企業の戦略・SWOT・財務分析
    Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Lyft Inc (LYFT)：企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Avalign Technologies Inc-医療機器分野：企業M&A・提携分析
    Summary Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners LP is a medical device company that offers cutting instruments. The company offers cutting instruments, cases and trays, german instruments and instruments and implant products. It manufactures instruments and imp …
  • McLean Electric Cooperative Inc：企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Agilent Technologies Inc (A)：企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • DEPObank – Banca Depositaria Italiana SpA：企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Tenneco Inc (TEN)：企業の財務・戦略的SWOT分析
    Tenneco Inc (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • C.A. Curtze Co. Inc.：企業の戦略・SWOT・財務分析
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CKE Restaurants Holdings Inc.：企業の戦略・SWOT・財務分析
    CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • HKS Inc：企業の戦略・SWOT・財務情報
    HKS Inc - Strategy, SWOT and Corporate Finance Report Summary HKS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Sinovac Biotech Ltd (SVA)：企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive i …
  • Amphastar Pharmaceuticals Inc (AMPH)-製薬・医療分野：企業M&A・提携分析
    Summary Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s product …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆